Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
98,410,264
-
Share change
-
+2,313,139
-
Total reported value
-
$309,535,197
-
Put/Call ratio
-
24%
-
Price per share
-
$3.15
-
Number of holders
-
123
-
Value change
-
+$8,132,941
-
Number of buys
-
46
-
Number of sells
-
69
Institutional Holders of PDL BIOPHARMA INC COM - COM (Y104L) as of Q3 2020
As of 30 Sep 2020,
PDL BIOPHARMA INC COM - COM (Y104L) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
98,410,264 shares.
The largest 10 holders included
BlackRock Inc., DIMENSIONAL FUND ADVISORS LP, Park West Asset Management LLC, RENAISSANCE TECHNOLOGIES LLC, Silver Point Capital L.P., VANGUARD GROUP INC, STATE STREET CORP, Madison Avenue Partners, LP, BRANDES INVESTMENT PARTNERS, LP, and NORTHERN TRUST CORP.
This page lists
123
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.